Claret Asset Management Corp Merck & Co., Inc. Transaction History

Claret Asset Management Corp

$611 Million
Q3 2024

A detailed history of Claret Asset Management Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Claret Asset Management Corp holds 8,030 shares of MRK stock, worth $773,369. This represents 0.15% of its overall portfolio holdings.

Number of Shares

8,030

Previous 8,045 0.19%

Holding current value

$773,369

Previous $996,000 8.43%

% of portfolio

0.15%

Previous 0.18%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$111.15 - $128.97 $1,667 - $1,934	-15 Reduced 0.19%	8,030 $912,000
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $25,626 - $27,522	207 Added 2.64%	8,045 $996,000
Q4 2023 Feb 12, 2024	SELL	$100.18 - $109.02 $2,504 - $2,725	-25 Reduced 0.32%	7,838 $854,000
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $1,544 - $1,714	15 Added 0.19%	7,863 $809,000
Q2 2023 Aug 09, 2023	BUY	$108.61 - $118.38 $8,145 - $8,878	75 Added 0.96%	7,848 $906,000
Q1 2023 Apr 18, 2023	SELL	$102.94 - $114.86 $10,294 - $11,486	-100 Reduced 1.27%	7,773 $827,000
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $1,690 - $1,899	-20 Reduced 0.25%	7,873 $678,000
Q2 2022 Jul 28, 2022	BUY	$83.49 - $94.64 $1,168 - $1,324	14 Added 0.18%	7,893 $720,000
Q1 2022 Apr 04, 2022	SELL	$73.51 - $82.4 $735 - $824	-10 Reduced 0.13%	7,879 $646,000
Q4 2021 Feb 07, 2022	SELL	$72.28 - $90.54 $2,602 - $3,259	-36 Reduced 0.45%	7,889 $605,000
Q3 2021 Dec 02, 2021	BUY	$71.68 - $78.83 $1,433 - $1,576	20 Added 0.25%	7,925 $595,000
Q2 2021 Aug 09, 2021	SELL	$70.31 - $77.77 $11,390 - $12,598	-162 Reduced 2.01%	7,905 $615,000
Q1 2021 May 04, 2021	SELL	$68.86 - $81.11 $12,601 - $14,843	-183 Reduced 2.22%	8,067 $622,000
Q4 2020 Feb 02, 2021	SELL	$71.77 - $79.65 $5,741 - $6,372	-80 Reduced 0.96%	8,250 $675,000
Q3 2020 Oct 29, 2020	SELL	$73.18 - $82.95 $28,540 - $32,350	-390 Reduced 4.47%	8,330 $691,000
Q2 2020 Aug 06, 2020	SELL	$70.42 - $80.13 $29,505 - $33,574	-419 Reduced 4.58%	8,720 $674,000
Q1 2020 Apr 06, 2020	SELL	$63.36 - $87.82 $126 - $175	-2 Reduced 0.02%	9,139 $703,000
Q4 2019 Jan 07, 2020	SELL	$77.58 - $87.54 $4,499 - $5,077	-58 Reduced 0.63%	9,141 $831,000
Q1 2019 Apr 29, 2019	SELL	$69.58 - $79.36 $2,226 - $2,539	-32 Reduced 0.35%	9,199 $765,000
Q4 2018 Feb 07, 2019	BUY	$65.24 - $75.71 $326 - $378	5 Added 0.05%	9,231 $705,000
Q3 2018 Oct 30, 2018	SELL	$57.69 - $67.84 $1,730 - $2,035	-30 Reduced 0.32%	9,226 $654,000
Q4 2017 Mar 27, 2018	BUY	$51.62 - $61.64 $477,794 - $570,539	9,256	9,256 $521,000

Others Institutions Holding MRK

# of Institutions

3,821

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $244B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Claret Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Claret Asset Management Corp with notifications on news.

Account

Claret Asset Management Corp Merck & Co., Inc. Transaction History